The Department of Justice's NAICS 325412 (Pharmaceutical Preparation Manufacturing) market: incumbents, spending trend, set-asides and open solicitations — from FY2026 USAspending awards and live SAM.gov notices.
Contract data as of Oct 18, 2026 (USAspending) · recent coverage verified weekly
| Quarter | Awards | Obligated | Change |
|---|---|---|---|
| Q1 FY2026 | 542 | $77.5M | — |
| Q2 FY2026 | 428 | $28.0M | -64% |
| Q3 FY2026 | 440 | $31.6M | +13% |
| Q4 FY2026 | 430 | $60.8M | +93% |
Federal fiscal quarters (Q1 = Oct–Dec). Awards are counted in the quarter they start; obligations are the award's obligated amount.
| # | Contractor | Obligated | Share |
|---|---|---|---|
| 1 | MCKESSON CORPORATION | $191.6M | 96.8% |
| 2 | TAKEDA PHARMACEUTICALS AMERICA, INC. | $1.3M | 0.7% |
| 3 | ACTELION PHARMACEUTICALS US, INC. | $1.0M | 0.5% |
| 4 | EXPRESS SCRIPTS HOLDING CO | $880K | 0.4% |
| 5 | SANOFI S A | $419K | 0.2% |
Registrations are rolled up to their corporate parent (USAspending parent UEI), so a company with several SAM registrations ranks once.
| Set-aside type | Obligated | Share |
|---|---|---|
| Small business set-aside | $0 | 0.0% |
| 8(a) | $0 | 0.0% |
| SDVOSB | $0 | 0.0% |
| WOSB / EDWOSB | $0 | 0.0% |
| HUBZone | $0 | 0.0% |
| No set-aside (full & open) | $3.6M | 100.0% |
Share of obligations on awards whose set-aside type is recorded — 2% of this market's dollars. Most USAspending bulk-archive records leave the field blank, so blank awards are excluded rather than counted as full & open.
No open solicitations right now. New notices post daily — get an alert when one does.
Links open the notice on SAM.gov.
Source: USAspending.gov contract awards (prime awards with a start date from Oct 1, 2025 through Sep 30, 2026), SAM.gov contract opportunities, and SBA size standards. Recompetes are contracts whose final end date — options included — falls in the next 12 months. Figures are recomputed when a new USAspending load lands. See our data sources.